Interestingly, miR-6741 was recently described as a potential biomarker for the severity of COVID-19, where a transient upregulation after dexamethasone treatment was associated with a poor prognosis; APOBEC3H and HNRNPA1L2, involved in antiviral defense, were identified as target genes [48]. This evidence concerns the gene APOBEC3H and COVID-19.